HMN 2025: How Unexpected lipid drop in weight problems might result in new therapies

When protective lipids decline, health risks increase
Deletion of Nogo-A/B improves hepatic glucose metabolism with out affecting physique weight in lean mice. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-56869-9

New analysis from Weill Cornell Medicine has uncovered a shocking offender underlying cardiovascular ailments in weight problems and diabetes—not the presence of sure fat, however their suppression. The study, printed Feb. 25 in Nature Communications, challenges the traditional perception {that a} kind of fats referred to as ceramides accumulates in blood vessels to trigger irritation and well being dangers.

Instead, their findings reveal that when ceramides lower in lining blood vessels, it may be damaging and trigger persistent sicknesses. Ironically, the findings might in the end result in therapies that preserve excessive ranges of those protecting lipids in sufferers with weight problems.

Ceramides are discovered all through the physique and within the endothelium, the skinny lining inside blood vessels. These waxy lipids regulate blood vessel tone, dilating or contracting vessels to modulate . They additionally assist forestall , maintaining blood flowing simply by the physique’s in depth freeway of arteries and veins.

“The widespread assumption within the subject was that top ranges of ceramides within the endothelium of blood vessels contributed to , however this conclusion was extrapolated from in vitro knowledge in cells,” stated Dr. Annarita Di Lorenzo, professor of pathology and laboratory medication at Weill Cornell Medicine.

“Ours is the primary in vivo study that measures the degrees of the lipids within the endothelial cells of an animal model. In fed a , ceramides don’t construct up—they lower in comparison with lean mice.”

Also engaged on this analysis are co-first authors Dr. Onorina L. Manzo, postdoctoral affiliate and Luisa Rubinelli, each in Dr. Di Lorenzo’s lab.

When protective lipids decline, health risks increase
The inhibition of ceramide de novo biosynthesis by Nogo-B in HFD mice leads to the suppression of each ceramide and S1P, contributing to vascular and metabolic problems. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-56869-9

Ceramide to the rescue

Dr. Di Lorenzo and her group found the significance of ceramides in blood vessels two years in the past. Together with Dr. Giuseppe Faraco, assistant professor of neuroscience at Weill Cornell Medicine, they discovered that decreased ranges of ceramides in in any other case wholesome mice causes extreme blood vessel irritation within the mind, clot formation and demise.

Last yr, the group reported that manufacturing will increase as a protecting response in a mouse model of coronary artery illness. Ultimately, when ceramide is damaged down by the physique it produces a compound referred to as sphingosine-1-phosphate (S1P), which builds up and protects mice towards heart problems. But when this course of does not work the mice are left weak.

The researchers additionally discovered that two proteins, Nogo-B and ORMDL, decreased the manufacturing of ceramides and S1P in weight problems. This lower results in elevated blood strain, impaired vascular regulation and better glucose ranges—all of which contribute to cardiometabolic circumstances that have an effect on the center (cardiovascular system) and vitality processing (metabolism), like diabetes, hypertension, coronary artery illness and stroke.

Maintaining stability

To perceive how these totally different molecules work together, the researchers examined what occurs in animal models. Mice with weight problems fed a high-fat weight loss plan had low ranges of ceramides and S1P, however excessive ranges of Nogo-B. These mice confirmed indicators of irritation, diabetes and hypertension.

But what occurs if the Nogo-B inhibitor wasn’t current? The researchers knocked out Nogo-B solely within the endothelium of blood vessels in a mouse model to seek out out.

“These mice have the identical physique weight and diabetes as controls, however their blood vessel well being is a lot better,” stated Dr. Di Lorenzo. “By knocking out this inhibitor, we preserved vascular well being. This additionally confirmed that the regulation of ceramide metabolism causes vascular dysfunction and irritation in weight problems.”

The paper means that focusing on this might have a number of helpful results within the remedy of cardiometabolic ailments associated to weight problems. “Nogo suppresses biosynthesis of ceramides, so if we are able to determine a drug that may block Nogo-B, we might restore ceramide ranges to a wholesome stability and this could battle not solely weight problems and diabetes, however would instantly hold blood vessels functioning correctly,” she stated.

More data:
Luisa Rubinelli et al, Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic ailments, Nature Communications (2025). DOI: 10.1038/s41467-025-56869-9

Citation:
Unexpected lipid drop in weight problems might result in new therapies (8)
9
unexpected-lipid-obesity-therapies.html

.
. The content material is offered for data functions solely.